홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.0
  1. 홈
  2. /반응

Hydrochloric Acid → 4-[6-(N-cyclopentylmethylcarbamoyl)-3-[2-(morpholinocarbonyl)ethyl]indol-1-ylmethyl]-3-methoxybenzoic acid

HRID 1198966
노트
인쇄 미리보기

반응식

HRID 1198966 반응식
[CH:1]1([CH2:6][NH:7][C:8]([C:10]2[CH:18]=[C:17]3[C:13]([C:14]([CH2:40][CH2:41][C:42]([N:44]4[CH2:49][CH2:48][O:47][CH2:46][CH2:45]4)=[O:43])=[CH:15][N:16]3[CH2:19][C:20]3[CH:37]=[CH:36][C:23]([C:24](NS(C4C=CC=CC=4)(=O)=O)=[O:25])=[CH:22][C:21]=3[O:38][CH3:39])=[CH:12][CH:11]=2)=[O:9])[CH2:5][CH2:4][CH2:3][CH2:2]1.BrCC1C=CC(C(OC(C)(C)C)=[O:57])=CC=1OC.Cl>CN(C)C1C=CN=CC=1.N1CCOCC1.O>[CH:1]1([CH2:6][NH:7][C:8]([C:10]2[CH:18]=[C:17]3[C:13]([C:14]([CH2:40][CH2:41][C:42]([N:44]4[CH2:45][CH2:46][O:47][CH2:48][CH2:49]4)=[O:43])=[CH:15][N:16]3[CH2:19][C:20]3[CH:37]=[CH:36][C:23]([C:24]([OH:25])=[O:57])=[CH:22][C:21]=3[O:38][CH3:39])=[CH:12][CH:11]=2)=[O:9])[CH2:5][CH2:4][CH2:3][CH2:2]1
참가 물질실험 절차후처리출처 및 근거반응 노트

참가 물질

7

반응물 3

HCID 313Hydrochloric AcidHCID 14523519Tert-butyl 4-(bromomethyl)-3-methoxybenzoateHCID 19867561N-[4-[6-(N-Cyclopentylmethylcarbamoyl)-3-[2-(morpholinocarbonyl)ethyl]indol-1-ylmethyl]-3-methyoxybenzoyl]benzenesulfonamide

생성물 1

HCID 150137814-[6-(N-cyclopentylmethylcarbamoyl)-3-[2-(morpholinocarbonyl)ethyl]indol-1-ylmethyl]-3-methoxybenzoic acid수율 41%

시약·촉매·용매 3

HCID 14284
4-(Dimethylamino)pyridine
촉매
HCID 962Water용매
HCID 8083Morpholine용매

실험 절차

The starting indole was obtained as follows: A solution of 4-[6-(N-cyclopentylmethylcarbamoyl)-3-(2-methoxycarbonylethyl)indol-1-ylmethyl)]-3-methoxybenzoic acid (0.68g)(prepared as described in Example 1, parts (a) through (i)) and 4-(dimethylamino)pyridine (0.17 g) in morpholine (4 ml) was heated at 80° for 48 hours under a nitrogen atmosphere. The reaction was diluted with water and acidified with 10% (v/v) hydrochloric acid. The resultant precipitate was collected by filtration and washed with water. The product was purified by recrystallization from ethyl acetate to give 4-[6-(N-cyclopentylmethylcarbamoyl)-3-[2-(morpholinocarbonyl)ethyl]indol-1-ylmethyl]-3-methoxybenzoic acid as a white powder (0.31 g, 41%); partial NMR (80 MHz, CDCl3) 1.2-1.8(m, 9H, cyclopentyl), 2.70(dd, 2H, CH2NH), 3.15(t, 2H, COCH2), 3.2-3.7(m, 8H, morpholino), 3.92(s, 3H, OCH3), 5.35(s, 2H, ArCH2), 6.58(t, 1H, NH), 7.17(d, 1H), 7.9(s, 1H, H7 -indole).

후처리

  1. filtrationThe resultant precipitate was collected by filtration
  2. washwashed with water
  3. customThe product was purified by recrystallization from ethyl acetate

출처 및 근거

ORD 기록
ord-e20f233ac859477f92c3e72c352fb979
출처 데이터셋
uspto-grants-1990_02
DOI
10.6084/m9.figshare.5104873.v1
특허 번호
US04898863

반응 노트

불러오는 중…

이 페이지에서참가 물질실험 절차후처리출처 및 근거반응 노트